| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 12/17/2009 | WO2009151644A2 Small molecule inhibitors of autotaxin methods of use |
| 12/17/2009 | WO2009151561A2 Methods and compounds for antimicrobial intervention |
| 12/17/2009 | WO2009150101A1 Pharmaceutical compositions comprising n-[2-((2r)-2-{[4-[(4-chlorophenyl)methyl]-l-oxo-2(ih)-phthalaz inyl]methyl}-l- pyrrolidinyl)ethyl]-4-(methyloxy)butanamide |
| 12/17/2009 | WO2009149920A1 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders |
| 12/17/2009 | WO2009149486A2 Compounds for treating diseases |
| 12/17/2009 | WO2009132093A3 Substituted arylcyclopentenes as therapeutic agents |
| 12/17/2009 | WO2009130296A3 Anti-alk1 antibodies and uses thereof |
| 12/17/2009 | WO2009117669A3 Treatment with opioid antagonists and mtor inhibitors |
| 12/17/2009 | WO2009112758A3 Novel use of zinc n-acetyltaurinate |
| 12/17/2009 | US20090312438 Compositions and Methods for Attenuating the Formation of A2E in the Retinal Pigment Epithelium |
| 12/17/2009 | US20090312430 Colchicine solid-state forms; methods of making; and methods of use thereof |
| 12/17/2009 | US20090312394 Protection against and treatment of age related macular degeneration |
| 12/17/2009 | US20090312390 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 12/17/2009 | US20090312337 Compositions containing alpha-2-adrenergic agonist components |
| 12/17/2009 | US20090312316 Novel compounds |
| 12/17/2009 | US20090312313 Compound having tgfbeta inhibitory activity and pharmaceutical composition comprising the same |
| 12/17/2009 | US20090312283 Branched hyaluronic acid and method of manufacture |
| 12/17/2009 | CA2727847A1 Compositions and methods for treating corneal inflammation |
| 12/17/2009 | CA2727605A1 Povidone iodine, a novel alternative preservative for ophthalmic compositions |
| 12/17/2009 | CA2723991A1 Compounds for treating diseases |
| 12/17/2009 | CA2722763A1 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders |
| 12/16/2009 | EP2133359A2 Recombinant haemophilus influenzae adhesin proteins |
| 12/16/2009 | EP2133083A1 Therapeutic agent for infectious skin or mucosal disease |
| 12/16/2009 | EP1940381B1 Ophthalmic pharmaceutical compositions based on amino acids and sodium hyaluronate |
| 12/16/2009 | EP1830848B1 Use of thiazolidinone derivatives for the treatment of solid tumors |
| 12/16/2009 | EP1429602B1 Methods for treating disorders using plant extracts |
| 12/16/2009 | CN101605531A Ophthalmic compositions containing a synergistic combination of three polymers |
| 12/16/2009 | CN101605529A Stable formulations, and methods of their preparation and use |
| 12/16/2009 | CN101602731A Metalloproteinase inhibitors |
| 12/16/2009 | CN101601842A Health care product for relieving and preventing ocular diseases and preparation method thereof |
| 12/16/2009 | CN101601828A Eyesight-recovering traditional Chinese medicine for treating optic neuritis and optic nerve atrophy |
| 12/16/2009 | CN101601817A Manufacturing method of black snake medicinal liquor for nourishing yin and dispelling wind-evil |
| 12/16/2009 | CN101601792A Preparation method of cornus and cistanche medicinal liquor |
| 12/16/2009 | CN101601773A Manufacturing method of tortoise plastron glue tonic wine |
| 12/16/2009 | CN101601757A Preparation method of medicinal liquor for tonifying kidney and improving eyesight |
| 12/16/2009 | CN101601691A Preparation method of liquid for curing eye diseases |
| 12/16/2009 | CN101601665A Use of 1r, 2s-methoxamine in preparing medicament for treating faecal incontinence and other conditions |
| 12/16/2009 | CN101601659A Glutathione enteric-coated pellet and preparation method thereof |
| 12/16/2009 | CN100569753C A crystalline of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide methanesulfonate a process for preparing the same |
| 12/16/2009 | CN100569291C Compositions containing alpha-2-adrenergic agonist components |
| 12/16/2009 | CN100569218C Benzydalysine eye drop and its preparing method |
| 12/15/2009 | US7632951 Inhibitors of integrin ανβ6 |
| 12/15/2009 | US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions |
| 12/15/2009 | US7632830 Lactam compounds and pharmaceutical use thereof |
| 12/15/2009 | US7632808 Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system |
| 12/15/2009 | CA2423354C Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications |
| 12/15/2009 | CA2348445C Compositions for the treatment and prevention of cardiovascular diseases |
| 12/15/2009 | CA2345295C Use of fused pyrrolocarbazoles in preventing/treating damage to sensory hair cells and cochlear neurons |
| 12/15/2009 | CA2334189C Bridged indenopyrrolocarbazoles |
| 12/15/2009 | CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof |
| 12/10/2009 | WO2009147442A1 Novel treatments |
| 12/10/2009 | WO2009147218A1 Pharmaceutical combination |
| 12/10/2009 | WO2009126682A3 Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis |
| 12/10/2009 | US20090306579 Delivery of corticosteroids through iontophoresis |
| 12/10/2009 | US20090306225 Auris formulations for treating otic diseases and conditions |
| 12/10/2009 | US20090306216 Use of Beta-Aminoalcohols in the Treatment of Inflammatory Disorders and Pain |
| 12/10/2009 | US20090306132 Use of derivatives of naphthalenesulphonic or quinolinesulphonic acid in the treatment of vasoproliferative ocular diseases |
| 12/10/2009 | US20090306122 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially of tyrosine and raf kinases |
| 12/10/2009 | US20090306111 Pharmaceutical Comprising PPAR Agonist |
| 12/10/2009 | US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 12/10/2009 | US20090306077 Novel n- (2-aminophenyl) benzamide derivative having urea structure |
| 12/10/2009 | US20090305991 33 Human Secreted Proteins |
| 12/10/2009 | US20090305982 Muteins of tear lipocalin and methods for obtaining the same |
| 12/10/2009 | US20090305365 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 12/10/2009 | US20090304591 Method and device for optical detection of the eye |
| 12/10/2009 | CA2726878A1 Novel treatments |
| 12/10/2009 | CA2726644A1 Pharmaceutical combination |
| 12/09/2009 | EP2131198A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 12/09/2009 | EP2130915A1 Cell capable of expressing lacritin at high level |
| 12/09/2009 | EP2130829A1 Novel hydroxyindole derivative |
| 12/09/2009 | EP2130828A1 Sulfonamide derivative |
| 12/09/2009 | EP2130548A2 Growth Hormone Releasing Peptides |
| 12/09/2009 | EP2130537A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 12/09/2009 | EP2130536A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 12/09/2009 | EP2129379A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors |
| 12/09/2009 | EP2129373A1 Novel use of genistein |
| 12/09/2009 | EP1554256B1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 12/09/2009 | EP1458754B1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 12/09/2009 | EP1392642B1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 12/09/2009 | EP1252144B1 Substituted glutarimides and use thereof il-12 production inhibitors |
| 12/09/2009 | EP1129110B1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 12/09/2009 | CN101600476A Punctal plugs and methods of delivering therapeutic agents |
| 12/09/2009 | CN101600475A Small compounds that correct protein misfolding and uses thereof |
| 12/09/2009 | CN101600425A Isosorbide mononitrate derivatives for the treatment of ocular hypertension |
| 12/09/2009 | CN101597324A Decapeptide inhibiting angiogenesis and use thereof |
| 12/09/2009 | CN101597294A 3-aminoalkaneacylamino-rutaecarpine and 3-aminoalkaneacylamino-7,8-dehydrorutaecarpine derivative |
| 12/09/2009 | CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 12/09/2009 | CN101596271A Medicament for treating suppurative otitis media and preparation method thereof |
| 12/09/2009 | CN101596243A External traditional Chinese medicine for treating pus running from ears |
| 12/09/2009 | CN101596208A Medicine composition for treating burns, scalds, tympanitis and ulceratiue stomatitis |
| 12/09/2009 | CN101596204A Compound fluconazole ointment and preparation method thereof |
| 12/09/2009 | CN100567483C FAD4, FAD5, FAD5-2 and FAD6 fatty acid desaturase enzyme family members and uses thereof |
| 12/09/2009 | CN100567325C VEGF receptor fusion protein and its use in preparation of medicament for treating eye disease |
| 12/09/2009 | CN100567266C Cannabinoid receptor ligands |
| 12/09/2009 | CN100566722C Method and composition for treatment of adenoviral ocular infections |
| 12/08/2009 | US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 12/08/2009 | US7629363 Diaryl substituted pyridinones |
| 12/08/2009 | US7629362 2-pyridine carboxamide derivatives |
| 12/08/2009 | US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/08/2009 | US7628988 Induce cell differentiation; process control |